Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

52.07
+0.29000.56%
Volume:2.70M
Turnover:140.24M
Market Cap:105.32B
PE:16.65
High:52.21
Open:51.57
Low:51.51
Close:51.78
52wk High:61.70
52wk Low:38.63
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.86
T/O Rate:0.14%
Dividend:1.85
Dividend Rate:3.56%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.38
PE(LYR):13.94

Loading ...

GSK Rises Tuesday, Outperforms Market

Dow Jones
·
Jul 29

GSK Licensor's Late-Stage China Study for Risvutatug Rezetecan in Bone Cancer Meets Primary Endpoint

MT Newswires Live
·
Jul 28

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 28

GSK Heading in Right Direction, but Investors Might Stay on Sidelines

Dow Jones
·
Jul 28

GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline

Dow Jones
·
Jul 28

Stock Track | GSK Soars 5.31% in Pre-Market on Strong Q2 Earnings Beat and Positive Oncology Pipeline Updates

Stock Track
·
Jul 28

Movement Alert|GlaxoSmithKline PLC Rises 4.44% in Regular Trading, Q2 Revenue and Earnings Both Beat Expectations with Cost Savings Target Boosting Confidence

Market Focus
·
Jul 28

GSK to Build New Global Research Center in Cambridge

MT Newswires Live
·
Jul 28

Sector Update: Healthcare Stocks Flat to Higher Pre-Bell Tuesday

MT Newswires Live
·
Jul 28

GSK's R&D Plan Looks Smart

Dow Jones
·
Jul 28

GSK's Savings Plan Can Offset Profitability Hit from HIV Patent Expiration

Dow Jones
·
Jul 28

GSK sees 2031 sales over GBP 40B

TIPRANKS
·
Jul 28

GSK sees 70p per share dividend for FY26

TIPRANKS
·
Jul 28

GSK initiates ‘Accelerate Growth’ program

TIPRANKS
·
Jul 28

GSK Q2 Core Earnings, Sales Rise; Reaffirms 2026 Guidance

MT Newswires Live
·
Jul 28

GSK reports Q2 core EPS 50.5p, up 9% at CER

TIPRANKS
·
Jul 28

Earnings Flash (GSK) GSK Posts Q2 Revenue of 8.41B Pounds ($11.17B), vs. FactSet Est of 8.28B Pounds

MT Newswires Live
·
Jul 28

Earnings Flash (GSK) GSK Posts Q2 Core EPS 50.5 Pence, vs. FactSet Est of $46.47 Pence

MT Newswires Live
·
Jul 28

Stock Track | GSK Soars 5% in Pre-Market on Strong Q2 Earnings Beat and Positive Oncology Data

Stock Track
·
Jul 28

GSK Q2 Adj. EPS $1.35 Beats $1.27 Estimate, Sales $11.280B Beat $10.790B Estimate

Benzinga Earnings
·
Jul 28